Table 2.

Clinical data of patients of four groups.

Case	Group	Eye	Age	Gender	Diagnosis	Intraoperative medications
1	Control	OD	47	F	iMH	TA/ICG
2	Control	OS	57	F	iMH	TA/ICG
3	Control	OD	57	F	iMH	TA/ICG
4	Control	OD	64	M	iMH	TA/ICG
5	Control	OD	46	F	iMH	TA/ICG
6	Control	OD	56	F	iMH	TA/ICG
7	Control	OS	77	F	iMH	TA/ICG
8	Control	OD	67	M	iMH	TA/ICG
9	Negative control	OS	69	F	iMH	TA/ICG
10	Negative control	OD	71	F	iMH	TA/ICG
11	Negative control	OS	49	F	PDR, DME	TA/ICG
12	Negative control	OS	56	M	PDR	TA/ICG
13	Negative control	OS	67	M	PDR	TA/ICG
14	Negative control	OD	47	F	DR, DME	TA/ICG
15	Negative control	OD	59	M	DR, DME	TA/ICG
16	Negative control	OD	56	F	DR	TA/ICG
17	No DME	OD	48	M	DR	TA/ICG
18	No DME	OS	69	F	DR	TA/ICG
19	No DME	OD	64	F	DR	TA/ICG
20	No DME	OS	51	M	DR	TA/ICG
21	No DME	OD	73	F	DR	TA/ICG
22	No DME	OD	48	F	DR	TA/ICG
23	No DME	OS	56	M	PDR	TA/ICG
24	No DME	OS	66	F	PDR	TA/ICG
25	No DME	OS	69	F	VH, DR	TA/ICG
26	DME	OS	52	M	DR, DME	TA/ICG
27	DME	OS	66	M	VH, DME	TA/ICG
28	DME	OD	59	M	VH, DME	TA/ICG
29	DME	OS	54	M	VH, DME	TA/ICG
30	DME	OS	52	F	DR, DME	TA/ICG
31	DME	OD	56	M	DR, DME	TA/ICG
32	DME	OS	79	M	DR, DME	TA/ICG
33	DME	OS	55	M	DR, DME	TA/ICG
34	DME	OS	50	F	DR, DME	TA/ICG
35	DME	OD	73	M	DR, DME	TA/ICG
36	DME	OS	59	M	PDR, DME	TA/ICG
37	DME	OS	63	F	PDR, DME	TA/ICG

OD: right eye; OS: left eye; iMH: idiopathic macular hole; PDR: proliferative diabetic retinopathy; DR: diabetic retinopathy; VH: vitreous hemorrhage; DME: diabetic macular edema; ICG: indocyanine green; TA: triamcinolone acetonide.